Safety of nivolumab/pembrolizumab in hepatitis B surface antigen-positive non-small cell lung cancer (NSCLC) patients.

被引：0
|
作者：
Xu, Chongrui
Tu, Hai-Yan
Sun, Yue-Li
Li, Yang-Si
Xu, Bing-Fei
Wang, Bin-Chao
Chen, Hua-Jun
Wang, Zhen
Zhou, Qing
Yang, Jin-Ji
Wu, Yi-Long
机构：
[1] South China Univ Technol, Sch Med, Guangdong Acad Med Sci, Guangdong Lung Canc Inst,Guangdong Prov Peoples H, Guangzhou, Guangdong, Peoples R China
[2] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21670
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Nivolumab and Pembrolizumab for Non-Small Cell Lung Cancer
    Morgensztern, Daniel
    Herbst, Roy S.
    CLINICAL CANCER RESEARCH, 2016, 22 (15) : 3713 - 3717
  • [2] Effectiveness and safety of atezolizumab, nivolumab and pembrolizumab in metastatic non-small cell lung cancer
    Burgos-San Jose, Amparo
    Colomer-Aguilar, Claudia
    Martinez-Caballero, Daniel
    Massuti-Sureda, Bartomeu
    FARMACIA HOSPITALARIA, 2021, 45 (03) : 121 - 125
  • [3] Patterns of Response to Nivolumab in Patients with Non-Small Cell Lung Cancer (NSCLC)
    Schmid, S.
    Diem, S.
    Krapf, M.
    Li, Q.
    Flatz, L.
    Leschka, S.
    Desbiolles, L.
    Klingbiel, D.
    Jochum, W.
    Fruh, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2419 - S2420
  • [4] A Rare Case of Non-Small Cell Lung Cancer Causing False Positive Hepatitis B Surface Antigen
    John, Jason J.
    Blonski, Wojciech
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S2085 - S2086
  • [5] The Efficacy and Safety of Nivolumab, Pembrolizumab, and Atezolizumab in Treatment of Advanced Non-small Cell Lung Cancer
    Chen, Rui
    Tao, Yuquan
    Xu, Xin
    Shan, Liang
    Jiang, Hongyuan
    Yin, Qilei
    Pei, Lingyan
    Cai, Feng
    Ma, Lifang
    Yu, Yongchun
    DISCOVERY MEDICINE, 2018, 26 (143) : 155 - 166
  • [6] Outcomes of Nivolumab in Elderly Patients (pts) with Non-Small Cell Lung Cancer (NSCLC)
    Bagley, Stephen
    Kothari, Shawn
    Aggarwal, Charu
    Bauml, Joshua
    Alley, Evan
    Evans, Tracey
    Kosteva, John
    Ciunci, Christine
    Thompson, Jeffrey
    Stonehouse-Lee, Susan
    Sherry, Victoria
    Gilbert, Elizabeth
    Eaby-Sandy, Beth
    Mutale, Faith
    Dilullo, Gloria
    Cohen, Roger
    Vachani, Anil
    Langer, Corey
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1289 - S1289
  • [7] Nivolumab in Non-Small Cell Lung Cancer (NSCLC): Facing the Reality
    Merimsky, O.
    Shamai, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2425 - S2425
  • [8] Radiogenomics in 332 metastatic non-small cell lung cancer (NSCLC) patients.
    Remon, Jordi
    Faivre, Laura
    Facchinetti, Francesco
    Bluthgen, Maria Virginia
    Pignon, Jean-Pierre
    Planchard, David
    Lacroix, Ludovic
    Besse, Benjamin
    Soria, Jean-Charles
    Caramella, Caroline
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [9] Efficacy and safety of necitumumab and pembrolizumab combination therapy in patients with stage IV non-small cell lung cancer (NSCLC)
    Besse, B.
    Garrido Lopez, P.
    Puente, J.
    Cortot, A.
    Olmedo Garcia, M. E.
    Perol, M.
    Gil, M.
    Chao, G.
    Shahidi, J.
    Bennouna, J.
    ANNALS OF ONCOLOGY, 2017, 28
  • [10] Organ-specific response to nivolumab in patients with non-small cell lung cancer (NSCLC)
    Schmid, Sabine
    Diem, Stefan
    Li, Qiyu
    Krapf, Mirjam
    Flatz, Lukas
    Leschka, Sebastian
    Desbiolles, Lotus
    Klingbiel, Dirk
    Jochum, Wolfram
    Fruh, Martin
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (12) : 1825 - 1832
12345